BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
PTEN
,
Response to oxidative stress
,
Lung cancer
,
Stem cell
,
Biofuel
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
influenza A H1N1
Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral bood mononuclear cells (PBMC) from healthy individuals after influenza vaccination
Children with complex seizures by influenza A (H1N1)pdm09 or rotavirus gastroenteritis
Nasal mucosa from patients with influenza A H1N1 pdm09 infection
Influenza A H1N1 patients blood miRNA expression profiles
Peripheral blood of healthy individuals inoculated with intranasal influenza A H1N1 or H3N2
Explore Curated Studies Results
Literature
Most Relevant Literature
Distribution and evolution of H1N1 influenza A viruses with adamantanes-resistant mutations worldwid…
Detection of H275Y oseltamivir resistance gene mutation among Influenza A(H1N1)pdm09 patients by all…
Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus …
Evolution and Phylodynamics of the Hemagglutinin Protein of Influenza A/(H1N1)pdm09 Virus Isolates f…
In Silico Design of an Oseltamivir Derivative with Increased Affinity against Wild-Type and Mutant V…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tomographic Findings in COVID-19 and Influenza H1N1
Antiviral Therapy for Influenza A H1N1
Novel Influenza A (H1N1) Surveillance Registry
Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants
A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ